Our Team Is Our Advantage
Very few people truly understand the cannabis industry. Our team has decades of experience in the pre rec-legal industry and makes a difference.
Unlike many companies rushing into cannabis, through our experience and relationships, we are able to see opportunities others don’t.
COME GROW WITH US
KARL KOTTMEIER
Very rarely, maybe once in a life time will anyone get an opportunity like this.The epicentre of this opportunity will be California and Chemistree has already established itself as a multifaceted player in that market.
Come join us in this growth story.
Sugar Leaf Case Study
We identify, re-organize and properly capitalize opportunities for sustainable growth. Read our case study on the turn around of SugarLeaf in Washington State.
CHEMISTREE INVESTEE IMMUNOFLEX™ COMPLETES CLINICAL STUDY AND SUBMITS US AND INTERNATIONAL PATENT APPLICATIONS
Vancouver, British Columbia, July 13th, 2021– Chemistree Technology Inc. (CSE: CHM and CHM.wt) (US OTCQB:
Chemistree Technology Is Building on the Nico Escondido’s Presence to Grow Market Share
Nico Escondido is a name players in the global cannabis industry understand very well. Acknowledging
Why New Jersey Is An Interesting Market For Chemistree
The American Cannabis industry is growing fast presenting numerous opportunities for cannabis companies. Medical marijuana
Our Team, Our Advantage
Team Chemistree
We are proud to bring together a team of career cannabis experts. Click here to learn more and connect with us.
Karl Kottmeier
President and CEO
Sheldon Aberman
Chief Cannabis Officer and Director
Doug Ford
Chief Financial Officer
Corporate Presentation
Industry knowledge
Chemistree will provide a public vehicle entity to investors who are looking to invest in a company that is vertically integrated and approaches the Cannabis and CBD industry from a United States Market perspective.